# Sai Parenterals Limited (SAIPARENT)

> SAIPARENT closed at ₹517.00 on 30 Oct 2026, market cap ₹2,284 cr, latest results for the quarter ended 30 Jun 2026. Revenue, profit, ROE, debt, own P/E range and sector-peer comparison from the SEBI filing.

Sai Parenterals Limited (NSE: SAIPARENT) closed at ₹517.00 on 30 Oct 2026, against a 52-week range of ₹400.00 – ₹706.00.

In the quarter ended 30 Jun 2026 (consolidated, filed 11 Aug 2026) it reported revenue of ₹179 cr and net profit of ₹8 cr, a 4.4% net margin.

No trailing P/E is published: only 3 filed quarters available — a trailing twelve months needs 4.

From the balance sheet dated 31 Mar 2026: return on equity 6.5%, ROCE 9.0%, debt-to-equity 0.65.

Against 66 Healthcare peers on NSE: Net margin higher than 14% of 64 sector peers; PBT margin higher than 11% of 64 sector peers; ROE higher than 14% of 64 sector peers.

## Key figures

| Figure | Value |
|---|---|
| Last close | ₹517.00 (30 Oct 2026) |
| Change 1 month / 6 months / 1 year | +2.1% / +6.7% / — |
| 52-week low – high | ₹400.00 – ₹706.00 |
| Market capitalisation | ₹2,284 cr |
| Quarter revenue | ₹179 cr |
| Quarter net profit | ₹8 cr |
| Net margin | 4.4% |
| Return on equity | 6.5% |
| ROCE | 9.0% |
| Debt / equity | 0.65 |
| Current ratio | 1.44 |
| Free cash flow | ₹75 cr |
| Average daily turnover (50 days) | ₹3.7 cr |

## Questions

### What were Sai Parenterals Limited's latest quarterly results?

For the quarter ended 30 Jun 2026, Sai Parenterals Limited reported revenue of ₹179 cr and net profit of ₹8 cr (consolidated), filed with the exchange on 11 Aug 2026.

### What is Sai Parenterals Limited's ROE?

Return on equity is 6.5% based on the balance sheet dated 31 Mar 2026.

### Does Sai Parenterals Limited have debt?

Debt-to-equity is 0.65 on the balance sheet dated 31 Mar 2026.

### What is SAIPARENT's 52-week high and low?

Over the last 52 weeks to 30 Oct 2026, SAIPARENT traded between ₹400.00 and ₹706.00.

Sector: [Healthcare](https://trinetra.trade/sectors/healthcare) · Page: https://trinetra.trade/fundamentals/SAIPARENT

_TRINETRA is a research and education tool. Nothing on this site is investment advice or a recommendation to buy or sell any security. Markets carry risk; do your own research and consult a SEBI-registered adviser before investing._